The SAFAR study is an on-going single-center prospective study recruiting consecutive patients with established hypertension (treated or untreated with antihypertensive drugs) or with suspected ...

The natural history of subclinical systolic and diastolic LV dysfunction in the general population is currently unknown. Serial imaging studies are required to clarify the progression of LV changes ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Evaluation of NT-proBNP in patients may lead to early exclusion of Left Ventricular dysfunction, according to a new study. The value and cost-effectiveness of screening for left ventricular (LV) ...

Severe hypothyroidism is associated with a high burden of systolic/diastolic ventricular dysfunction and myocardial ...

Left ventricular diastolic dysfunction is associated with worse health status among patients with severe aortic stenosis, but TAVR leads to clinically meaningful symptomatic improvements regardless of ...

Advanced left ventricular diastolic dysfunction (LVDD) in patients undergoing TAVR is linked with almost a fourfold increase in risk of postprocedural death as early as 30 days postprocedure, ...

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global ...

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global health priority. An echocardiogram, or cardiac ultrasound, is one of the ...

Because life expectancy and the prevalence of risk factors such as hypertension, obesity and diabetes are rising globally, heart failure (HF) is growing into a major health problem. Impairment of left ...